2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$39.32+$0.55 (+1.42%)
Price as of Aug 03, 2026 9:19 AM EDT- $1.4BMarket Cap
- 24.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$39.32+$0.55 (+1.42%)
Earnings Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 6 |
Momentum Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 6.23% | ||
12-Month Momentum | 35.39% | ||
3-Month Risk Adjusted Momentum | 20.09% | ||
12-Month Risk Adjusted Momentum | 55.56% |
True Yield
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -3.53% |
Financial Health Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |